Workshop Report – Interventions to Reduce the Development and Transmission of AMR

We are happy to share the report of the recent online workshop entitled “Interventions to Reduce the Development and Transmission of AMR”. The workshop was hosted by The French National Research Agency (ANR), in close colla

We are happy to share the report of the recent online workshop hosted by The French National Research Agency (ANR).

We are happy to share the report of the recent online workshop entitled “Interventions to Reduce the Development and Transmission of AMR”. The workshop was hosted by The French National Research Agency (ANR), in close collaboration with JPIAMR. Please find the full report here.

Trailer – Overview of AMR science policy and funding

JPIAMRs Laura Marin presents the article published in the journal Trends in Microbiology on AMR, science policy, innovation, public health and funding. The article summarises the many recent AMR projects (JPIAMR, TATFAR, CARB-X, GARDP, ND4BB , G7/ G20 Health Ministers, and more) and is a good general reference and entry to the AMR community. The article is co-authored by Arjon Van Hengel (Directorate-General for Research & Innovation, European Commission) and Laura Marin (JPIAMR).

 

Pre-announcement: Call on AMR Diagnostics and Surveillance

JPIAMR is pleased to pre-announce a joint transnational research call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods.  The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant.

The projected call budget is approx. 20 million Euro.

To read more about the call, please click here.

Report – Countries Should Increase Funding for AMR Research by 50%

Today we are reached by the final report from DRIVE-AB with the headline: “Revitalizing the Antibiotic Pipeline“. The context is that “The current pipeline for innovative antibiotics in various stages of R&D is insufficient, potentially delivering no more than one innovative antibiotic for a “critical” World Health Organization (WHO) priority pathogen within the next five years.”, the report say in the beginning.  A key reason for the DRIVE-AB report is to bring recommendations and guidance in the present context, when we are facing increased antibiotic resistance on a global scale.

One of the main recommendations is that countries should increase funding for AMR.

“Countries should make long-term commitments to continue financing of antibacterial R&D and ideally increase push funding by about 50 per cent.”, states the report.

DRIVE-AB finds that: “There may be capacity within existing multinational grant funding agencies – e.g. CARB-X, GARDP, JPIAMR (Joint Programming Initiative on Antimicrobial Resistance) – to absorb and effectively deploy more capital.”

So, we are happy to see that JPIAMR is acknowledged as a key organisation and vehicle, among others,  who are trusted with the mission to fund even more research in order to harness AMR on a global scale. Since JPIAMR is coordinating research and funding for it’s 26 member nations – it fits very well to expand the operations in this direction.

The Drive-AB report continues: “Owing to the existing pipeline, much of this immediate funding should be placed in early- and mid-stage grants until the pipeline becomes more robust. Granting agencies should have specific calls for research targeting pathogens that pose the most urgent public health threats (e.g. WHO’s priority pathogens list for the discovery phase and TPPs for the development phase).”

The ongoing JPIAMR call for “New targets, compounds and tools – innovating against antibiotic resistant bacteria“, is a perfect example how countries are pooling resources and research to collaborate. This call responds to WHOs list of priority pathogens just as the report recommends.

However, funding is linked with the ability to both reach and enable researcher to apply for funds. This is something many more entities in the AMR field could collaborate on to a greater extent. If researchers are not aware of available funds and contexts to support research, we may miss opportunities to support research that can be life changing for the many.

The 6th Transnational Call is Now Open

The sixth transnational call for research projects for the JPIAMR within the ERA-NET JPI-EC-AMR

THE CALL IS OPEN

The JPIAMR, in partnership with sixteen member countries; Belgium, Czech Republic, Egypt, Finland, France, Germany, Ireland, Israel, Italy, Latvia, Norway, Poland, Romania, Spain, Sweden and Switzerland, is launching a sixth joint call for transnational research projects. The total budget of the 6th Call is approx. 14.4 million Euro.

The call targets research in the following topic:

Innovations against antibiotic-resistant bacteria: new targets, compounds and tools. Fundamental, translational research, with the exception of clinical trials.

Call procedure

The 6th Call has a two-step procedure. With a first stage, a pre-proposal submission, from which selected applicants will be invited to submit a full proposal, the second stage. The final funding decision will be announced in October / November 2018.

Deadlines

The pre-proposal submission deadline is March 7, 2018, (17:00, CET).
The full proposal submission deadline is June 14, 2018, (17.00, CET).

Information and application

For more detailed information and links to application process, please visit the page about the 6th Call.

6th Call Secretariat and National Points of Contact

The 6th Call Secretariat is hosted by the French National Research Agency, ANR.

All questions on national rules, eligibility, etc. should be directed to the national contacts, for contact information please visit the page about the 6th Call.

Spread the News

Reach out to researchers in participating countries. Use the template below and link to the page about the 6th call.

20 Transnational Research Projects enters next step of fifth Call

Now twenty transnational research projects are invited to submit full applications within the JPIAMRs fifth Joint Call on Prevention and Intervention Strategies to control AMR infections.

Earlier this year the JPIAMR announced its fifth joint call on “Prevention and Intervention Strategies to control AMR infections”. As the deadline for submitting a pre-proposal passed on March 21st, 53 transnational consortia had submitted applications. After evaluation by a panel of international reviewers, twenty of the projects have been invited to submit a full application. The deadline for the full application is on July 4th. For more information, please visit the call page.

Facts about the fifth joint call:

The JPIAMR, in partnership with fifteen countries: Belgium, Canada, Czech Republic, Germany, Ireland, Israel, Italy, Latvia, Netherlands, Norway, Poland, Romania, Spain, Sweden and Switzerland, launched a fifth joint call for transnational research Projects.

The call targets research in the following topic:

Comparison of prevention, control and intervention strategies for AMR infections through multidisciplinary studies, including One Health approaches.